LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Wells Fargo upgrades this medical device maker, cites improving industry trends

Chaim Potok by Chaim Potok
April 24, 2023
in Investing
Wells Fargo upgrades this medical device maker, cites improving industry trends
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


Wells Fargo is getting more bullish on shares of Medtronic . Analyst Larry Biegelsen upgraded the medical device maker to overweight from equal weight in a Sunday note, saying that shares should benefit from improving medtech trends and a “maturing” product pipeline. “We rate MDT Overweight as we believe that the company will benefit as underlying medtech markets improve as staffing shortages ease in major markets,” he said. “We also see support from MDT’s pipeline.” He expects the company to benefit from an easing of staffing shortages as major markets, including Europe and China, look past the Covid-19 pandemic and handle a “backlog of deferred procedures.” Shares gained about 1.5% in premarket trading. Medtronic’s stock has gained a little over 10% year to date. Shares could surge about 17% from Friday’s close given the firm’s revised price target to $100 a share, up from $77. Within the company’s product pipeline, Biegelsen sees the biggest potential upside from the U.S. Food and Drug Administration’s approval of its upgraded insulin pump known as 780G. He called the approval, which was announced earlier this month , a “major milestone” able to “help stop the bleeding in MDT’s diabetes business.” The company’s diabetes business has grown roughly 15% year to date in areas outside the U.S. where the product’s been in the market since 2020, Biegelsen noted. MDT YTD mountain Shares so far in 2023 Other potential tailwinds include the launch of its pulsed field ablation product used to treat issues like an irregular heartbeat, or atrial fibrillation. Traction of Medtronic’s Hugo robot should also benefit shares. According to Biegelsen, Medtronic’s valuation also looks attractive, trading at a sharp discount to peers. The company trades at 16.5 times consensus 2023 earning per share, versus a median of 21.9 times for the broader group. “We believe once MDT moves past its FY2024 guidance in May, the stock can re-rate on the overall medtech recovery and product pipeline,” he wrote. — CNBC’s Michael Bloom contributed reporting



Source link

You might also like

This oil stock finally has technical momentum on its side and is ‘one of the best in the market,’ Josh Brown says

A recent breakout points to a ‘stealth bull market’ in this exchange stock, according to the charts

These stocks reporting earnings next week, including Nvidia, have histories of beating Wall Street’s expectations

Share30Tweet19
Previous Post

Hinges for furniture: How to pick the right one for your home

Next Post

Eli Lilly to sell hypoglycemia treatment for up to $1.1 billion in cash and milestone payments to Amphastar

Chaim Potok

Chaim Potok

Recommended For You

This oil stock finally has technical momentum on its side and is ‘one of the best in the market,’ Josh Brown says
Investing

This oil stock finally has technical momentum on its side and is ‘one of the best in the market,’ Josh Brown says

November 13, 2025
A recent breakout points to a ‘stealth bull market’ in this exchange stock, according to the charts
Investing

A recent breakout points to a ‘stealth bull market’ in this exchange stock, according to the charts

November 13, 2025
These stocks reporting earnings next week, including Nvidia, have histories of beating Wall Street’s expectations
Investing

These stocks reporting earnings next week, including Nvidia, have histories of beating Wall Street’s expectations

November 13, 2025
Caterpillar is on fire this year. A look at what’s driving the industrial giant — and where it could go from here
Investing

Caterpillar is on fire this year. A look at what’s driving the industrial giant — and where it could go from here

November 13, 2025
Next Post
Eli Lilly to sell hypoglycemia treatment for up to .1 billion in cash and milestone payments to Amphastar

Eli Lilly to sell hypoglycemia treatment for up to $1.1 billion in cash and milestone payments to Amphastar

Related News

These assets protect against inflation — Why you should be cautious before investing

These assets protect against inflation — Why you should be cautious before investing

February 21, 2025
Best Black Friday 2023 Green Deals: e-bikes, power stations, tools, more

Best Black Friday 2023 Green Deals: e-bikes, power stations, tools, more

November 24, 2023
‘Crunch decision’ on Palace of Westminster restoration to face new government

‘Crunch decision’ on Palace of Westminster restoration to face new government

October 25, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?